gilead

Hi everyone, Please be nice I’m just wondering: I have an upcoming interview with Gilead and was curious if they do a drug testing. Thank you!!

ViiV Rukobia rep got fired for breaking every pharma rule. He was compliance nightmare. His boss knew and said and did nothing because rep’s #s were good. Boss lied to save his ass, bullshit move. Fact they didn’t fire boss is horse shit with everything this guy does. Rep AND boss both should...

When did ViiV reps start gifting docs vegetables? Bringing non GSK-ViiV pharmacist on calls and lunches? ViiV so hard up they’ll break pharma rules? A lot of bad stuff goes on in Florida but vegetables lmao!!! Dude, Gilead reporting you and your boss. Offices talk pal.

Gilead offerring 185 no pension to exp rinvoq and humira reps. Pension only worth 20 k a year of saved. Reps making 130 a year could do well. Abbvie reps have the access. Salanty should take notice as i see 30 % pouch rate if culture isnt restored under taigo. He is killing it soflty.

Last week, Gilead failed in Phase 3 clinical trial for NASH drug. Today, Intercept has become the first player in the NASH area to complete a pivotal Phase 3 study in patients with liver fibrosis.

Gilead Sciences reported a 2.6% decline in revenue for the fourth quarter. The results were hurt by lower product sales in Europe and in other locations. Chronic hepatitis C virus product sales plunged 50.8% due to lower average selling price and lower sales volume of Harvoni and Epclusa across...

Celgene's second quarter results beat estimates and the company lifted 2018 outlook. Celgene will not be increasing the price of its products this year. https://news.alphastreet.com/celgene-q2-2018-earnings/

Earnings slipped more than 40% in the second quarter of FY2018 for Gilead. The company updated that John F. Milligan will step down as CEO and President. https://news.alphastreet.com/gilead-sciences-q2-2018-earnings-results/

Gilead Sciences (GILD) reported a 43% dip in earnings for the first quarter due to lower product sales and prescription trends. Higher competition and lower sales of certain hepatitis C products too impacted sales during the quarter. Infographics of the results. The market has huge hopes for...

Geoff Cotton and Jim Meyers retiring at the same time? Suspicious.

Just took a position with Gilead and I live in the snowbelt area. I was wondering what kind of company car options we receive upon completion of training? Not particular and definitely grateful, just hoping an option or two have 4 wheel drive. Thanks in advance.

GILD revenue down 13%; profit down 18%; product sales down 14%. Poor sales of hepatitis C drugs with lower sales predicted for the year. Hope the $12 bln acqusition of Kite Pharma should help the company.